Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...

Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.

A new study suggests that semaglutide, the active ingredient in Ozempic, may help decrease liver fat, inflammation, and ...

Semaglutide effectively treats liver disease in two thirds of patients ... Researchers chose to investigate semaglutide as a potential treatment because this class of drug helps reduce fat ...

The diabetes and weight loss drug semaglutide reversed liver scarring and inflammation. It’s among several drugs in the works for the condition MASH.

A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a serious form of fatty liver disease, a new study has found.

New research reveals that semaglutide significantly improves liver health in MASH patients. A new study published in the New England Journal of Medicine reveals that semaglutide significantly improves ...

Semaglutide, which is traditionally a treatment for type 2 diabetes, was given to participants who had been diagnosed with a life-threatening form of liver disease called metabolic dysfunction ...

Semaglutide, available under the brand names Ozempic and Wegovy, may help decrease the risk of major adverse cardiovascular ...

Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly ... Researchers chose to investigate semaglutide as a potential treatment because this class of drug helps reduce fat ...